Strata Critical Medical Statistics
Total Valuation
SRTA has a market cap or net worth of $352.31 million. The enterprise value is $294.38 million.
Important Dates
The last earnings date was Tuesday, March 3, 2026, before market open.
| Earnings Date | Mar 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTA has 86.99 million shares outstanding. The number of shares has increased by 5.93% in one year.
| Current Share Class | 86.99M |
| Shares Outstanding | 86.99M |
| Shares Change (YoY) | +5.93% |
| Shares Change (QoQ) | +2.72% |
| Owned by Insiders (%) | 12.75% |
| Owned by Institutions (%) | 56.36% |
| Float | 62.97M |
Valuation Ratios
The trailing PE ratio is 8.04.
| PE Ratio | 8.04 |
| Forward PE | n/a |
| PS Ratio | 1.79 |
| Forward PS | 1.28 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 2.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 7.12 |
| EV / Sales | 1.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.38, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.38 |
| Quick Ratio | 5.11 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.01% and return on invested capital (ROIC) is -3.11%.
| Return on Equity (ROE) | -8.01% |
| Return on Assets (ROA) | -2.71% |
| Return on Invested Capital (ROIC) | -3.11% |
| Return on Capital Employed (ROCE) | -4.12% |
| Weighted Average Cost of Capital (WACC) | 16.00% |
| Revenue Per Employee | $602,878 |
| Profits Per Employee | $126,443 |
| Employee Count | 327 |
| Asset Turnover | 0.68 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.64% in the last 52 weeks. The beta is 2.16, so SRTA's price volatility has been higher than the market average.
| Beta (5Y) | 2.16 |
| 52-Week Price Change | +44.64% |
| 50-Day Moving Average | 4.66 |
| 200-Day Moving Average | 4.64 |
| Relative Strength Index (RSI) | 36.76 |
| Average Volume (20 Days) | 820,783 |
Short Selling Information
The latest short interest is 6.58 million, so 7.56% of the outstanding shares have been sold short.
| Short Interest | 6.58M |
| Short Previous Month | 5.56M |
| Short % of Shares Out | 7.56% |
| Short % of Float | 10.44% |
| Short Ratio (days to cover) | 7.48 |
Income Statement
In the last 12 months, SRTA had revenue of $197.14 million and earned $41.35 million in profits. Earnings per share was $0.50.
| Revenue | 197.14M |
| Gross Profit | 41.13M |
| Operating Income | -12.61M |
| Pretax Income | -20.07M |
| Net Income | 41.35M |
| EBITDA | -5.71M |
| EBIT | -12.61M |
| Earnings Per Share (EPS) | $0.50 |
Full Income StatementBalance Sheet
The company has $61.23 million in cash and $3.31 million in debt, with a net cash position of $57.92 million or $0.67 per share.
| Cash & Cash Equivalents | 61.23M |
| Total Debt | 3.31M |
| Net Cash | 57.92M |
| Net Cash Per Share | $0.67 |
| Equity (Book Value) | 279.07M |
| Book Value Per Share | 3.22 |
| Working Capital | 106.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$48.91 million and capital expenditures -$9.60 million, giving a free cash flow of -$58.51 million.
| Operating Cash Flow | -48.91M |
| Capital Expenditures | -9.60M |
| Depreciation & Amortization | 6.90M |
| Net Borrowing | n/a |
| Free Cash Flow | -58.51M |
| FCF Per Share | -$0.67 |
Full Cash Flow StatementMargins
Gross margin is 20.86%, with operating and profit margins of -6.40% and 20.97%.
| Gross Margin | 20.86% |
| Operating Margin | -6.40% |
| Pretax Margin | -10.18% |
| Profit Margin | 20.97% |
| EBITDA Margin | -2.90% |
| EBIT Margin | -6.40% |
| FCF Margin | n/a |
Dividends & Yields
SRTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.93% |
| Shareholder Yield | -5.93% |
| Earnings Yield | 11.74% |
| FCF Yield | -16.61% |
Analyst Forecast
The average price target for SRTA is $7.81, which is 92.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.81 |
| Price Target Difference | 92.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTA has an Altman Z-Score of 4.54 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.54 |
| Piotroski F-Score | 3 |
